A Vindicara company
AXIISIUM

Audit-grade AI for
acute myeloid leukemia.

Most cell classifiers give you a guess. Axiisium gives you a signed, verifiable record of every call.

NPM1 from morphology · preliminary
0.894 ±0.066
patient-level AUROC, leakage-free cross-validation
Preliminary result: 5-fold cross-validation on 48 held-out patients (8 NPM1-positive). In the range of published literature; external-cohort validation pending.
Enter → New · runs air-gapped, still signed →
Research Use Only. Not for diagnostic use.